Gotto AM; Moon J.Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia.Ex- pert Rev Cardiovasc.2010.90-1079Pitavasta tin for the treatment ofprimary hyperlipidemia and mixed dyslipidemia. Gotto AM,Moon J. Ex-pert Rev Cardiovasc . 2010...
Primary Hyperlipidemia and Mixed DyslipidemiaDrug TrialsShow entriesDrugDrug NamePhaseStatusCount DB01076 Atorvastatin 3 Completed 1 DB09303 Evolocumab 3 Completed 1 Showing 1 to 2 of 2 entries ‹ 1 › Stay up-to-date with the latest from DrugBank! Subscribe Downloads Data Library Academic...
Many patients with high levels of serum total cholesterol have a concomitant elevation of serum triglyceride levels and thus have mixed hyperlipidemia. In this study, 13 patients with mixed hyperlipidemia were treated with the cholesterol-lowering drug lovastatin to determine its effectiveness. In 9 of...
Kinetic bases of the primary hyperlipidemias: studies of apolipoprotein B turnover in genetically defined subjects Eur. J. Clin. Invest., 10 (1980), pp. 161-172 CrossrefView in ScopusGoogle Scholar 9 S. Reynisdottir, M. Eriksson, B. Angelin, P. Arner Impaired activation of adipocyte lip...
60 Slight gender differences for primary endpoint were reported, as women were more protected than men (9.1% vs 11.2% in combination therapy groups of respective gender).59 Part of Table 2 ACCORD LIPID and EYE TRIAL outcomes58,60 Endpoint Simvastatin + fenofibrate (N) Primary outcomes Secondary...
possibly because China has stricter discharge criteria. When studying the association between LOS and such patient characteristics as age, gender, Charlson Comorbidity Index (CCI), and history of cancer, heart disease, hypertension, hyperlipidemia, and diabetes, the impact of these variables on the LO...
Objective To analyze the curative effect and safety of atorvastatin combining fenofibrate in treatment of mixed hyperlipidemia. Methods The elderly patients with mixed hyperlipidemia(n=120, male 68, female 52, aged from 60 to 82 and average age=67.2±5.9) were chosen from June 2010 to June 2013...
These effects are pointing out that PS-HOSO may serve as a functional ingredient for metabolic syndrome or diabetic sufferers, which not only influences body weight, but also prevents or reverses insulin resistance and hyperlipidemia.Background Metabolic syndrome represents a cluster of metabolic ...
Patients with mixed hyperlipidemia usually are in need of combination therapy to achieve low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) target values for reduction of cardiovascular risk. This study investigated the efficacy and safety of adding a new hypolipidemic agent, coenzyme A...
Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein composition, lipoprotein-modifying enzymes, and postprandial lipoprotein metabolism. Atherosclerosis, 117: 253–261, 1995Foger B, Trobinger G, Ritsch A, Lechleitner M, Hopferwieser T, Menzel HJ et al. (...